Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 24-Oct-11 4:54 PM View:  | Qvt Associates Gp LLC 10% Owner | Anadys Pharmaceuticals Inc. (ANDS) | 21-Oct-11 | Market Sale | 364,918 | $3.68 | $1,342,900.00 | (7%) 5.52M to 5.15M | 0% |
| 24-Oct-11 4:54 PM View: | Qvt Associates Gp LLC 10% Owner | Anadys Pharmaceuticals Inc. (ANDS) | 20-Oct-11 | Market Sale | 5,252,700 | $3.68 | $19,329,900.00 | (49%) 10.77M to 5.52M | 0% |
| 19-Oct-11 4:08 PM View: | Qvt Associates Gp LLC 10% Owner | Anadys Pharmaceuticals Inc. (ANDS) | 17-Oct-11 | Market Sale | 650,100 | $3.68 | $2,392,370.00 | (6%) 11.42M to 10.77M | (< 1%) |
| 05-Jan-11 6:44 PM View: | Qvt Associates Gp LLC 10% Owner | Anadys Pharmaceuticals Inc. (ANDS) | 03-Jan-11 | Market Purchase | 34,209 | $1.41 | $48,234.70 | < 1% 11.39M to 11.42M | 163% |
| 03-Jan-11 6:04 PM View: | Qvt Associates Gp LLC 10% Owner | Anadys Pharmaceuticals Inc. (ANDS) | 30-Dec-10 | Market Purchase | 300 | $1.48 | $444.00 | < 1% 11.39M to 11.39M | 161% |
| 03-Jan-11 6:04 PM View: | Qvt Associates Gp LLC 10% Owner | Anadys Pharmaceuticals Inc. (ANDS) | 29-Dec-10 | Market Purchase | 317,014 | $1.45 | $460,170.00 | 3% 11.07M to 11.39M | 166% |
| 29-Dec-10 7:30 PM View: | Qvt Associates Gp LLC 10% Owner | Anadys Pharmaceuticals Inc. (ANDS) | 28-Dec-10 | Market Purchase | 544,690 | $1.44 | $783,134.00 | 5% 10.52M to 11.07M | 168% |
| 29-Dec-10 7:30 PM View: | Qvt Associates Gp LLC 10% Owner | Anadys Pharmaceuticals Inc. (ANDS) | 27-Dec-10 | Market Purchase | 1,714,210 | $1.30 | $2,228,470.00 | 19% 8.81M to 10.52M | 197% |
| 27-Dec-10 4:55 PM View: | Qvt Associates Gp LLC 10% Owner | Anadys Pharmaceuticals Inc. (ANDS) | 23-Dec-10 | Market Purchase | 285,790 | $1.21 | $345,806.00 | 3% 8.52M to 8.81M | 219% |
| 22-Oct-10 4:55 PM View: | Qvt Associates Gp LLC 10% Owner | Anadys Pharmaceuticals Inc. (ANDS) | 20-Oct-10 | Market Purchase | 150,000 | $1.65 | $247,500.00 | 2% 8.37M to 8.52M | 133% |
| 19-Oct-10 5:05 PM View: | Qvt Associates Gp LLC 10% Owner | Anadys Pharmaceuticals Inc. (ANDS) | 15-Oct-10 | Market Purchase | 2,301,390 | $1.78 | $4,094,050.00 | 38% 6.07M to 8.37M | 116% |
| 20-Sep-10 5:14 PM View: | Qvt Associates Gp LLC 10% Owner | Anadys Pharmaceuticals Inc. (ANDS) | 16-Sep-10 | Market Purchase | 8,000 | $1.78 | $14,240.00 | < 1% 6.07M to 6.07M | 116% |
| 14-Sep-10 5:29 PM View: | Qvt Associates Gp LLC 10% Owner | Anadys Pharmaceuticals Inc. (ANDS) | 10-Sep-10 | Market Purchase | 25,000 | $1.80 | $45,000.00 | < 1% 6.04M to 6.07M | 113% |
| 03-Sep-10 5:00 PM View: | Qvt Associates Gp LLC 10% Owner | Anadys Pharmaceuticals Inc. (ANDS) | 01-Sep-10 | Market Purchase | 25,000 | $1.74 | $43,500.00 | < 1% 6.02M to 6.04M | 121% |
| 31-Aug-10 5:04 PM View: | Qvt Associates Gp LLC 10% Owner | Anadys Pharmaceuticals Inc. (ANDS) | 30-Aug-10 | Market Purchase | 25,000 | $1.77 | $44,250.00 | < 1% 5.99M to 6.02M | 117% |
| 31-Aug-10 5:04 PM View: | Qvt Associates Gp LLC 10% Owner | Anadys Pharmaceuticals Inc. (ANDS) | 27-Aug-10 | Market Purchase | 6,000 | $1.75 | $10,500.00 | < 1% 5.98M to 5.99M | 119% |
| 27-Aug-10 5:12 PM View: | Qvt Associates Gp LLC 10% Owner | Anadys Pharmaceuticals Inc. (ANDS) | 26-Aug-10 | Market Purchase | 15,700 | $1.75 | $27,475.00 | < 1% 5.97M to 5.98M | 119% |
| 27-Aug-10 5:12 PM View: | Qvt Associates Gp LLC 10% Owner | Anadys Pharmaceuticals Inc. (ANDS) | 25-Aug-10 | Market Purchase | 17,400 | $1.70 | $29,580.00 | < 1% 5.95M to 5.97M | 126% |
| 25-Aug-10 4:50 PM View: | Qvt Associates Gp LLC 10% Owner | Anadys Pharmaceuticals Inc. (ANDS) | 24-Aug-10 | Market Purchase | 34,900 | $1.73 | $60,377.00 | < 1% 5.92M to 5.95M | 122% |
| 25-Aug-10 4:50 PM View: | Qvt Associates Gp LLC 10% Owner | Anadys Pharmaceuticals Inc. (ANDS) | 23-Aug-10 | Market Purchase | 27,000 | $1.79 | $48,330.00 | < 1% 5.89M to 5.92M | 115% |
| 23-Aug-10 5:10 PM View: | Qvt Associates Gp LLC 10% Owner | Anadys Pharmaceuticals Inc. (ANDS) | 20-Aug-10 | Market Purchase | 4,000 | $1.77 | $7,080.00 | < 1% 5.89M to 5.89M | 117% |
| 23-Aug-10 5:10 PM View: | Qvt Associates Gp LLC 10% Owner | Anadys Pharmaceuticals Inc. (ANDS) | 19-Aug-10 | Market Purchase | 16,000 | $1.79 | $28,640.00 | < 1% 5.87M to 5.89M | 115% |
| 18-Aug-10 5:18 PM View: | Qvt Associates Gp LLC 10% Owner | Anadys Pharmaceuticals Inc. (ANDS) | 17-Aug-10 | Market Purchase | 5,000 | $1.80 | $9,000.00 | < 1% 5.86M to 5.87M | 113% |
| 18-Aug-10 5:18 PM View: | Qvt Associates Gp LLC 10% Owner | Anadys Pharmaceuticals Inc. (ANDS) | 16-Aug-10 | Market Purchase | 35,000 | $1.86 | $65,100.00 | < 1% 5.83M to 5.86M | 107% |
| 16-Aug-10 5:12 PM View: | Qvt Associates Gp LLC 10% Owner | Anadys Pharmaceuticals Inc. (ANDS) | 12-Aug-10 | Market Purchase | 32,500 | $1.94 | $63,050.00 | < 1% 5.8M to 5.83M | 98% |
| 05-Aug-10 4:59 PM View: | Qvt Associates Gp LLC 10% Owner | Anadys Pharmaceuticals Inc. (ANDS) | 03-Aug-10 | Market Purchase | 50,400 | $1.99 | $100,296.00 | < 1% 5.75M to 5.8M | 93% |
| 08-Jul-10 4:49 PM View: | Qvt Associates Gp LLC 10% Owner | Anadys Pharmaceuticals Inc. (ANDS) | 06-Jul-10 | Market Purchase | 30,000 | $1.98 | $59,400.00 | < 1% 5.72M to 5.75M | 94% |
| 06-Jul-10 5:13 PM View: | Qvt Associates Gp LLC 10% Owner | Anadys Pharmaceuticals Inc. (ANDS) | 02-Jul-10 | Market Purchase | 56,800 | $1.94 | $110,192.00 | 1% 5.66M to 5.72M | 98% |
| 21-Oct-08 8:54 PM View: | Flynn James E 10% Owner | Anadys Pharmaceuticals Inc. (ANDS) | 18-Oct-08 | Market Sale | 460,000 | $2.18 | $1,002,800.00 | (13%) 3.6M to 3.14M | (< 1%) |
| 28-Aug-08 1:33 PM View: | Scangos George A Director | Anadys Pharmaceuticals Inc. (ANDS) | 26-Aug-08 | Market Purchase | 10,000 | $2.70 | $27,000.00 | 43% 23.19K to 33.19K | 1% |
| 30-May-08 8:55 PM View: | Worland Stephen T President and CEO Director | Anadys Pharmaceuticals Inc. (ANDS) | 30-May-08 | Option Exercise | 33,898 | $2.95 | $99,999.10 | 14% 247.12K to 281.02K | 30% |
| 19-Nov-07 2:23 PM View: | Glover James T SVP, Operations and CFO | Anadys Pharmaceuticals Inc. (ANDS) | 16-Nov-07 | Market Purchase | 600 | $2.00 | $1,200.00 | 4% 13.57K to 14.17K | 34% |
| 19-Nov-07 2:23 PM View: | Glover James T SVP, Operations and CFO | Anadys Pharmaceuticals Inc. (ANDS) | 15-Nov-07 | Market Purchase | 1,200 | $2.09 | $2,510.00 | 10% 12.37K to 13.57K | 29% |
| 13-Nov-07 4:03 PM View: | Glover James T SVP, Operations and CFO | Anadys Pharmaceuticals Inc. (ANDS) | 09-Nov-07 | Market Purchase | 3,401 | $2.10 | $7,142.10 | 38% 8.97K to 12.37K | 28% |
| 13-Nov-07 4:03 PM View: | Glover James T SVP, Operations and CFO | Anadys Pharmaceuticals Inc. (ANDS) | 08-Nov-07 | Market Purchase | 1,599 | $2.10 | $3,357.90 | 22% 7.37K to 8.97K | 28% |
| 14-Sep-07 6:58 PM View: | Papadopoulos Stelios Director | Anadys Pharmaceuticals Inc. (ANDS) | 14-Sep-07 | Market Purchase | 2,869 | $2.30 | $6,598.70 | < 1% 811.34K to 814.21K | 17% |
| 10-Sep-07 5:55 PM View: | Papadopoulos Stelios Director | Anadys Pharmaceuticals Inc. (ANDS) | 06-Sep-07 | Market Purchase | 200 | $2.30 | $460.00 | < 1% 811.14K to 811.34K | 17% |
| 05-Sep-07 8:53 PM View: | Papadopoulos Stelios Director | Anadys Pharmaceuticals Inc. (ANDS) | 05-Sep-07 | Market Purchase | 89,333 | $2.30 | $205,466.00 | 12% 721.8K to 811.14K | 17% |
| 05-Sep-07 8:56 PM View: | Williams Douglas E Director | Anadys Pharmaceuticals Inc. (ANDS) | 04-Sep-07 | Market Purchase | 2,000 | $2.36 | $4,720.00 | 80% 2.5K to 4.5K | 14% |
| 04-Sep-07 6:55 PM View: | Worland Stephen T President and CEO Director | Anadys Pharmaceuticals Inc. (ANDS) | 04-Sep-07 | Market Purchase | 13,236 | $2.35 | $31,095.60 | 6% 225.87K to 239.11K | 14% |
| 05-Sep-07 8:53 PM View: | Papadopoulos Stelios Director | Anadys Pharmaceuticals Inc. (ANDS) | 31-Aug-07 | Market Purchase | 32,913 | $2.22 | $73,116.20 | 5% 688.89K to 721.8K | 21% |
| 04-Sep-07 6:55 PM View: | Worland Stephen T President and CEO Director | Anadys Pharmaceuticals Inc. (ANDS) | 31-Aug-07 | Market Purchase | 12,200 | $2.11 | $25,714.20 | 6% 213.67K to 225.87K | 28% |
| 05-Sep-07 8:55 PM View: | Scangos George A Director | Anadys Pharmaceuticals Inc. (ANDS) | 31-Aug-07 | Market Purchase | 22,188 | $2.17 | $48,226.50 | 2219% 1.0K to 23.19K | 24% |
| 04-Sep-07 6:55 PM View: | Worland Stephen T President and CEO Director | Anadys Pharmaceuticals Inc. (ANDS) | 30-Aug-07 | Market Purchase | 124,564 | $2.00 | $249,128.00 | 140% 89.11K to 213.67K | 34% |
| 17-Aug-07 5:47 PM View: | Papadopoulos Stelios Director | Anadys Pharmaceuticals Inc. (ANDS) | 17-Aug-07 | Market Purchase | 38,989 | $2.15 | $83,826.40 | 6% 649.9K to 688.89K | 25% |
| 16-Aug-07 8:26 PM View: | Xanthopoulos Kleanthis G Director | Anadys Pharmaceuticals Inc. (ANDS) | 16-Aug-07 | Market Purchase | 6,500 | $2.15 | $13,957.50 | 4% 178.04K to 184.54K | 25% |
| 15-Aug-07 7:03 PM View: | Freddo James L Chief Medical Officer | Anadys Pharmaceuticals Inc. (ANDS) | 15-Aug-07 | Market Purchase | 10,000 | $2.22 | $22,250.00 | 333% 3.0K to 13.0K | 72% |
| 16-Aug-07 1:12 PM View: | Glover James T SVP, Operations and CFO | Anadys Pharmaceuticals Inc. (ANDS) | 15-Aug-07 | Market Purchase | 1,000 | $2.17 | $2,169.00 | 16% 6.37K to 7.37K | 24% |
| 14-Aug-07 4:42 PM View: | Fritz Lawrence C President and CEO Director | Anadys Pharmaceuticals Inc. (ANDS) | 14-Aug-07 | Market Purchase | 5,691 | $2.20 | $12,519.10 | 10% 54.31K to 60.0K | 22% |
| 14-Aug-07 4:42 PM View: | Fritz Lawrence C President and CEO Director | Anadys Pharmaceuticals Inc. (ANDS) | 13-Aug-07 | Market Purchase | 14,309 | $2.34 | $33,419.80 | 36% 40.0K to 54.31K | 15% |
